Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Brain Neoplasms × cemiplimab × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 6 Melanoma 3 Skin Neoplasms 2 Carcinoma, Squamous Cell 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Neoplasm Metastasis 1 Kidney Neoplasms 1 Eyelid Squamous Cell Carcinoma 1 Cutaneous Squamous Cell Carcinoma 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Merkel Cell 1 Carcinoma, Large Cell 1 Carcinoma, Hepatocellular 1 Brain Neoplasms 1 Anus Neoplasms 1 Adenocarcinoma 1

Interventions

Radiosurgery 21 Radiotherapy 19 Temozolomide 15 Lomustine 8 Bevacizumab 7 Surgical Procedures, Operative 6 Procarbazine 6 Vincristine 5 Nivolumab 5 Memantine 4 Filgrastim 4 Etoposide 4 Cisplatin 4 Carboplatin 4 Sodium Chloride 3 Radiation 3 Magnetic Resonance Spectroscopy 3 Granulocyte Colony-Stimulating Factor 3 Cyclophosphamide 3 Corticotropin-Releasing Hormone 3 icotinib 2 etoposide phosphate 2 efaproxiral 2 X-Rays 2 Tranexamic Acid 2 Tf-CRM107 2 Specimen Handling 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy, Conformal 2 Platinum 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05317858 2025-12-10

LIMITLESS

InSightec

Phase 3 Recruiting

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡